SCHEMBL2833291

SCHEMBL2833291

CCOc1ccc(Br)cc1C=CC(=O)N1CCC(N2CCCC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL3 Q96JM7 5/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
L3MBTL4 Q8NA19 2/20 0.47
MBTD1 Q05BQ5 2/20 0.46
HPGD P15428 2/20 0.43
TSHR P16473 1/20 0.43
KDM4E B2RXH2 1/20 0.42
AR P10275 1/20 0.42
LMNA P02545 2/20 0.41
GPR183 P32249 2/20 0.41
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13090286 1.00 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL3L3MBTL1L3MBTL4MBTD1
SCHEMBL13636007 0.92 SMN1; SMN2 (0.47) SMN1; SMN2L3MBTL1HPGDTSHRKDM4E
SCHEMBL4381584 0.92 SMN1; SMN2 (0.47) SMN1; SMN2L3MBTL1HPGDTSHRKDM4E
SCHEMBL14190929 0.91 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1HPGDTSHRKDM4E
SCHEMBL4381901 0.91 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1HPGDTSHRKDM4E
SCHEMBL3767758 0.85 GPR183 (0.41) SMN1; SMN2HPGDTSHRKDM4EAR
SCHEMBL3767754 0.85 GPR183 (0.41) SMN1; SMN2HPGDTSHRKDM4EAR
SCHEMBL14218062 0.82 GPR183 (0.61) SMN1; SMN2HPGDTSHRKDM4EAR
SCHEMBL13090259 0.81 PELI1 (0.52) SMN1; SMN2L3MBTL3L3MBTL1L3MBTL4MBTD1
SCHEMBL14190909 0.80 GPR183 (0.55) SMN1; SMN2HPGDTSHRKDM4EAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed